These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2847192)

  • 1. Endogenous Na,K-ATPase inhibitor(s) and atrial natriuretic peptides: are they interrelated?
    Haupert GT
    Prog Biochem Pharmacol; 1988; 23():71-6. PubMed ID: 2847192
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytochemical demonstration of an endogenous inhibitor of Na-K ATPase and its relationship to familial arterial hypertension].
    de Wardener H
    Nephrologie; 1987; 8(1):3-6. PubMed ID: 3035398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of Na+, K+-ATPase inhibition by atrial natriuretic factor in rat renal medulla.
    Bełtowski J; Górny D; Marciniak A
    J Physiol Pharmacol; 1998 Jun; 49(2):271-83. PubMed ID: 9670110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An inhibitor of nerve cell membrane Na,K-ATPase. Isolation and general characteristics].
    Elaev NR; Baĭgil'dina AA
    Biokhimiia; 1994 Mar; 59(3):389-94. PubMed ID: 8180271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing effect of atrial natriuretic factor on Na, K-ATPase activity in rat kidney.
    Górny D; Korzeniowska J; Marciniak A; Pielecki J
    J Physiol Pharmacol; 1994 Mar; 45(1):173-81. PubMed ID: 8043906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Purification of an endogenous inhibitor of sodium-potassium-ATPase].
    Cloix JF; Miller ED; Pernollet MG; Devynck MA; Meyer P
    C R Seances Acad Sci III; 1983 Feb; 296(5):213-6. PubMed ID: 6303528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
    Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
    Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of the Na,K-ATPase inhibitor from hypothalamus.
    Haupert GT
    Prog Biochem Pharmacol; 1988; 23():10-21. PubMed ID: 2847182
    [No Abstract]   [Full Text] [Related]  

  • 9. Physiological inhibitors of Na, K-ATPase: concept and status.
    Haupert GT
    Prog Clin Biol Res; 1988; 268B():297-320. PubMed ID: 2851808
    [No Abstract]   [Full Text] [Related]  

  • 10. Atrial natriuretic peptide regulates release of Na+-K+-ATPase inhibitor from rat brain.
    Crabos M; Ausiello DA; Haupert GT; Cantiello HF
    Am J Physiol; 1988 Jun; 254(6 Pt 2):F912-7. PubMed ID: 2837911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Affinity chromatographic study of the changes in the endogenous Na+-K+-ATPase inhibitor during sodium loading in man].
    Cloix JF; Henning G; Crabos M; Delva P; Meyer P
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1251-5. PubMed ID: 6098236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
    Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of soybean lipoxygenase on Na+/K+-ATPase activity in vitro.
    Kumarathasan R; Leenen FH
    Can J Physiol Pharmacol; 2000 Sep; 78(9):691-5. PubMed ID: 11007531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endogenous activators and inhibitors of Na, K-ATPase induced by acetylcholine].
    Elaev NR; Andreev VP; Shavrina NV
    Biull Eksp Biol Med; 1983 Feb; 95(2):40-2. PubMed ID: 6297634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Variations in the plasma concentrations of atrial natriuretic factor and endogenous digitalis compounds during acute volume expansion in the conscious rat].
    Morris M; Devynck MA; Pernollet MG; Meyer P
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():105-8. PubMed ID: 2847669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Na,K-ATPase inhibitors in hypertension and end-stage renal disease.
    Bargman JM
    Perit Dial Int; 1997; 17(6):536-40. PubMed ID: 9655151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An endogenous inhibitor of Na,K-ATPase isolated from human plasma inhibits the acid pump of the stomach.
    Mårdh S
    Prog Clin Biol Res; 1988; 268B():417-22. PubMed ID: 2851820
    [No Abstract]   [Full Text] [Related]  

  • 18. A role for the sodium, potassium adenosine triphosphatase (Na+,K+ ATPase) enzyme in degranulation of rat basophilic leukaemia cells.
    Gentile DA; Skoner DP
    Clin Exp Allergy; 1996 Dec; 26(12):1449-60. PubMed ID: 9027446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous inhibitors of the Na,K pump.
    Doris PA
    Miner Electrolyte Metab; 1996; 22(5-6):303-10. PubMed ID: 8933501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive inhibition of (Na/K)-ATPase by furylethylenes with respect to potassium ions.
    Breier A; Vrbanová A; Docolomanský P; Bohácová V; Ziegelhöffer A
    Gen Physiol Biophys; 1996 Aug; 15(4):291-307. PubMed ID: 9088927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.